BRISBANE, Australia - Oventus Medical has signed agreements with two new sleep groups, Tri Hospital Sleep and Ontario Sleep Care, both in Canada. Under these agreements Oventus O2Vent devices will be offered to patients at nine sites. “These businesses have been delivering high quality respiratory care for many years, even decades,” said Dr. Chris Hart, founder and CEO. “Oventus is proud that such well-respected sleep groups in North America have chosen to strengthen their existing sleep offering by adopting our treatment platform.” Oventus also has an agreement with Aeroflow Healthcare in the U.S. whereby Aeroflow is introducing O2 Vent devices throughout its locations and direct-to-consumer platform, as well as through agreements with referring sleep clinics across the southeastern U.S. Tri Hospital in Ontario, which provides diagnostics and treatment for OSA, plans to implement lab-in-lab facilities in its largest location with 14 beds of sleep diagnostics. Ontario Sleep Care, which provides treatment for OSA, will offer O2Vent Optima and ExVent therapy across its network for CPAP-intolerant individuals.